XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Cash flows from operating activities:    
Net income/(loss) $ 11,992,629 $ (1,532,715)
Adjustments to reconcile net income/(loss) to net cash used in operating activities:    
Depreciation and other amortization 267,669 265,289
Loss/(gain) on change in fair value of warrant liability 1,635,652 (3,792,788)
Stock-based compensation 582,549 956,284
Deferred income taxes, net 2,967,402 (655,139)
Loss on extinguishment of Term Loan 4,981,461 0
Non-cash interest expense 887,132 2,230,153
Changes in assets and liabilities:    
Accounts receivable (32,443,665) (2,169,083)
Inventory (1,751,459) 517,724
Prepaid expenses and other assets 1,203,690 942,599
Accounts payable, accrued expenses and other liabilities (4,421,690) (2,304,892)
Deferred revenue 8,332,405 1,204,135
Net cash used in operating activities (5,766,225) (4,338,433)
Cash flows from investing activities:    
Capital expenditures (15,501) (8,948)
Net cash used in investing activities (15,501) (8,948)
Cash flows from financing activities:    
Payment of employee tax obligations for common stock tendered (9,746) (56,590)
Repurchase of common stock (16,216,170) 0
Repayment of Term Loan (85,913,459) 0
Net cash used in financing activities (102,139,375) (56,590)
Net decrease in cash, cash equivalents and restricted cash (107,921,101) (4,403,971)
Cash, cash equivalents and restricted cash at the beginning of period 160,986,934 180,396,910
Cash, cash equivalents and restricted cash at end of period 53,065,833 175,992,939
Supplemental disclosure of non-cash activities:    
Conversion of warrants to common stock 0 1,172,801
Issuance of common stock upon cashless exercise $ 0 $ 118,500